May. 27 at 1:43 PM
$HURA Inside a tumor, there are more than cancer cells. There is an entire environment around it made of immune cells, blood vessels, and structures that can either help the body fight the disease or be turned into protection for the tumor itself. This is one of the key reasons why immunotherapies can lose effectiveness over time.
A big part of this resistance comes from immune-suppressing cells that “switch off” the immune response and prevent T-cells from doing their job. TuHURA Biosciences is focused on addressing this problem from multiple angles, not just targeting the tumor, but also the environment that allows it to hide. Its programs work across different mechanisms that drive this immune suppression.
The goal is to restore immune activity where it has been blocked, helping existing therapies potentially work better in more patients. As more data comes in, HURA continues building a picture around how this approach could apply across different cancer settings over time.
